Header Logo

Connection

Margaret Cusick to Proto-Oncogene Proteins c-mdm2

Back to Details
This is a "connection" page, showing publications Margaret Cusick has written about Proto-Oncogene Proteins c-mdm2.
Margaret Cusick
Connection Strength
0.055
Proto-Oncogene Proteins c-mdm2
  1. A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma. Sci Transl Med. 2025 Feb 19; 17(786):eadn6274.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.